Gregor Andelfinger retweeted
Trametinib, a mitogen-activated protein kinase inhibitor, may reduce morbidity & mortality in children w/ severe #cvHCM caused by pathogenic variants in the RAS/ mitogen-activated protein kinase signaling pathway.
Read more: bit.ly/3C3Cj60 #JACCBTS #cvSurg
Gregor Andelfinger retweeted
Syndrome de #Noonan: un médicament contre le cancer jugé prometteur pour prévenir l’apparition de graves problèmes cardiaques chez les enfants atteints de cette maladie génétique rare. @GregAndelfinger
tinyurl.com/yu27k4km
Hot off the press! Excited to share our work ‘Impact of MEK Inhibition on
Childhood RASopathy-Associated
Hypertrophic Cardiomyopathy’ published in JACC BTS! Huge shoutout to all co-authors who stuck with us!! jacc.org/doi/epdf/10.1016/j.…
Also, a very interesting tutorial from Daphne Hsu! jacc.org/doi/epdf/10.1016/j.…
Gregor Andelfinger retweeted
The Ghersi Lab is hiring! We're seeking passionate PhD students and postdocs to join our team at the brand-new Sainte-Justine Research Center. If you're excited about studying blood stem cell formation using zebrafish development, apply now! More info at ghersilab.com🩸
Gregor Andelfinger retweeted
Replying to @WeinsteinConf @GregAndelfinger
Great questions and engagements from the participants. I think - and hope! - they had as much fun as we had!
Gregor Andelfinger retweeted
Check out the first release of our @nf_core @nextflowio pipeline for processing @ResolveBioSci Molecular Cartography data🤩! Had a lot of fun working on this with @KresBestak 🎉. Reach out to us if you have any questions or need help getting started!
Pipeline release! nf-core/molkart v1.0.0 - Spatial Circuit!
Please see the changelog: github.com/nf-core/molkart/r…
Gregor Andelfinger retweeted
Join us for the 2024 Weinstein Cardiovascular Development and Regeneration Conference in Montreal, May 15-17! Registration and abstract submission are now open at weinstein2024.org/en
Please share, retweet and distribute! #WeinsteinCVD2024
Gregor Andelfinger retweeted
Great pleasure to visit @rmarinjuez group and share our research @ChuSteJustine! Get so many interesting questions and discussion with people from the amazing group! 😃 – at Montréal, Québec
How to criss cross a heart: a how to in this awesome story from Sigolène Meilhac's lab!!!
Torsion of the heart tube by shortage of progenitor cells : identification of Greb1l as a genetic determinant of criss-cross heart in mice biorxiv.org/content/10.1101/…
A spectacular finale by Debbie Yelon @WeinsteinConf San Diego 2023! What a wonderful meeting!! We are looking forward to hosting you all in Montreal 2024!
Acan downregulation in parvalbumin GABAergic cells reduces spontaneous recovery of fear memories -
congrats Marisol, Graziella!! It's now out in Molecular Psychiatry:
rdcu.be/da9E8
Gregor Andelfinger retweeted
Very happy our study using pooled CRISPR screens in endothelial cells to study coronary artery disease risk variants🫀has been accepted in @PLOSGenetics 🎉.
Really grateful, we had such an amazing team including @GLettre, @melibeau1 , @kenslo and everyone involved, to work with!
1/Extremely excited to report the publication in @PLOSGenetics or our CRISPR screens aimed at characterizing variants associated with coronary artery disease in endothelial cells: journals.plos.org/plosgeneti…
Gregor Andelfinger retweeted
Join us for the 2023 Weinstein Cardiovascular Development and Regeneration Conference in San Diego, May 4-6! Registration and abstract submission are open at weinstein-conferences.org.
Gregor Andelfinger retweeted
I am deeply shocked and sorry to learn that Jeff Robbins is no longer with us. He was truly a dedicated mentor, scientist, colleague, and, for me, above and beyond. We will truly miss him, but his science will remain with us forever! Rest in Peace, Jeff!!
Gregor Andelfinger retweeted
Check out this new study by the Di Cristo lab and collaborators @CR_CHUSJ, looking at the cellular mechanisms behind the memory of fear 🧠😱!
Happy @GregAndelfinger lab was able to contribute a small piece to this effort with Drop-seq, to enable Single-Cell analysis!
This Post is from an account that no longer exists. Learn more
New record: response that paper was not sent out for review after 53 days of website telling us manuscript was under consideration:

























